Dakofounded In 1966 By Danish Medical Doctor Niels Harboeis A Global Leader In Cancer Diagnostics And Pathology Solutionsacquired By Agilent Technologies In 2012Dako Specializes In Developing And Manufacturing Advanced Diagnostic Systemsincluding Immunohistochemistryihcand In Situ Hybridizationishtechnologiesthe Company Has Production Facilities In Glostrupdenmarkand Carpinteriacaliforniaand Operates Subsidiaries In The U S Chinabraziland Other Regions Dako Offers A Range Of Diagnostic Testsincluding The Herceptestthe First Fda Approved Companion Diagnostic Test For Her2 Positive Breast Cancerand The Her2 Cish Pharmdx Kit For Gastric Cancer Diagnosticsthe Company Also Provides Automation Systems Such As The Autostainerlink 48Dako Omnisand Coverstainerwhich Enhance Efficiency In Laboratory Workflowsdako Serves Hospital Laboratoriesresearch Institutionsand Pathology Labs Worldwidewith Its Products Recognized As Industry Standards In Oncology Diagnostics
